Beam Therapeutics Inc. (NASDAQ:BEAM) Given Average Recommendation of “Buy” by Analysts
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned an average recommendation of “Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned an average recommendation of “Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the […]
